Effect of high-fat diet feeding on hypothalamic redox signaling and central blood pressure regulation

Hypertension Research

Volumn 32, Issue 11, 2009, Pages 983-988

  Erdos, Benedek ^a,b   Broxson, Christopher S ^a   Cudykier, Idan ^a,b   Basgut, Bilgen ^a,b   Whidden, Melissa ^a,b   Landa, Tessa ^a,b   Scarpace, Philip J ^b   Tümer, Nihal ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CATECHOLAMINE; INDUCIBLE NITRIC OXIDE SYNTHASE; MANGANESE SUPEROXIDE DISMUTASE; NEURONAL NITRIC OXIDE SYNTHASE; NEUROPEPTIDE Y; PROTEIN P47; PROTEIN P67; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; TRIACYLGLYCEROL; TYROSINE 3 MONOOXYGENASE;

ADRENAL MEDULLA; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE REGULATION; CHOLESTEROL BLOOD LEVEL; CIRCADIAN RHYTHM; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVITY; HEART RATE; HYPOTHALAMUS; LIPID DIET; LOCOMOTION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PEPTIDE SYNTHESIS; PROTEIN EXPRESSION; RAT; SPRAGUE DAWLEY RAT; SYSTOLIC BLOOD PRESSURE; TELEMETRY; TISSUE LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ADRENAL MEDULLA; ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; BLOTTING, NORTHERN; BLOTTING, WESTERN; CATECHOLAMINES; DIETARY FATS; HEART RATE; HYPOTHALAMUS; MALE; MOTOR ACTIVITY; NADPH OXIDASE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY; RESTRAINT, PHYSICAL; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL; TELEMETRY; TYROSINE 3-MONOOXYGENASE;

EID: 71049187575     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2009.129     Document Type: Article

References (39)

1. Barnes MJ, Lapanowski K, Conley A, Rafols JA, Jen KL, Dunbar JC. High fat feeding is associated with increased blood pressure, sympathetic nerve activity and hypothalamic mu opioid receptors. Brain Res Bull 2003; 61: 511-519.
2. Vaz M, Jennings G, Turner A, Cox H, Lambert G, Esler M. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 1997; 96: 3423-3429.
3. Phillips MI, Sumners C. Angiotensin II in central nervous system physiology. Regul Pept 1998; 78: 1-11.
4. Boustany CM, Brown DR, Randall DC, Cassis LA. AT1-receptor antagonism reverses the blood pressure elevation associated with diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 2005; 289: R181-R186.
5. Bokil HS, Porter JP. Brain angiotensin type 1 receptor expression and function in the Zucker obese rat. Neurosci Lett 2000; 281: 139-142.
6. Zimmerman MC, Lazartigues E, Lang JA, Sinnayah P, Ahmad IM, Spitz DR, Davisson RL. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res 2002; 91: 1038-1045.
7. Wang G, Anrather J, Huang J, Speth RC, Pickel VM, Iadecola C. NADPH oxidase contributes to angiotensin II signaling in the nucleus tractus solitarius. J Neurosci 2004; 24: 5516-5524.
8. Erdos B, Broxson CS, King MA, Scarpace PJ, Tumer N. Acute pressor effect of central angiotensin II is mediated by NAD(P)H-oxidase-dependent production of superoxide in the hypothalamic cardiovascular regulatory nuclei. J Hypertens 2006; 24: 109-116.
9. Mayorov DN, Head GA, De Matteo R. Tempol attenuates excitatory actions of angiotensin II in the rostral ventrolateral medulla during emotional stress. Hypertension 2004; 44: 101-106.
10. Gao L, Wang W, Li YL, Schultz HD, Liu D, Cornish KG, Zucker IH. Sympathoexcitation by central ANG II: Roles for AT1 receptor upregulation and NAD(P)H oxidase in RVLM. Am J Physiol Heart Circ Physiol 2005; 288: H2271-H2279.
11. Zanzinger J. Mechanisms of action of nitric oxide in the brain stem: role of oxidative stress. Auton Neurosci 2002; 98: 24-27.
12. Kimura Y, Hirooka Y, Sagara Y, Ito K, Kishi T, Shimokawa H, Takeshita A, Sunagawa K. Overexpression of inducible nitric oxide synthase in rostral ventrolateral medulla causes hypertension and sympathoexcitation via an increase in oxidative stress. Circ Res 2005; 96: 252-260.
13. Dobrian AD, Davies MJ, Schriver SD, Lauterio TJ, Prewitt RL. Oxidative stress in a rat model of obesity-induced hypertension. Hypertension 2001; 37: 554-560.
14. Stepp DW. Impact of obesity and insulin resistance on vasomotor tone: nitric oxide and beyond. Clin Exp Pharmacol Physiol 2006; 33 407-414.
15. Erdos B, Snipes JA, Miller AW, Busija DW. Cerebrovascular dysfunction in zucker obese rats is mediated by oxidative stress and protein kinase C. Diabetes 2004; 53: 1352-1359.
16. Hong M, Li S, Fournier A, St-Pierre S, Pelletier G. Role of neuropeptide Y in the regulation of tyrosine hydroxylase gene expression in rat adrenal glands. Neuroendocrinology 1995; 61: 85-88.
17. Levin BE, Dunn-Meynell AA, Balkan B, Keesey RE. Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats. Am J Physiol 1997; 273: R725-R730.
18. Erdos B, Broxson CS, Landa T, Scarpace PJ, Leeuwenburgh C, Zhang Y, Tumer N. Effects of life-long caloric restriction and voluntary exercise on age-related changes in levels of catecholamine biosynthetic enzymes and angiotensin II receptors in the rat adrenal medulla and hypothalamus. Exp Gerontol 2007; 42: 745-752.
19. Truett AA, Borne AT, Poincot MA, West DB. Autonomic control of blood pressure and heart rate in obese hypertensive dogs. Am J Physiol 1996; 270: R541-R549.
20. Antic V, Van Vliet BN, Montani JP. Loss of nocturnal dipping of blood pressure and heart rate in obesity-induced hypertension in rabbits. Auton Neurosci 2001; 90: 152-157.
21. Dobrian AD, Davies MJ, Prewitt RL, Lauterio TJ. Development of hypertension in a rat model of diet-induced obesity. Hypertension 2000; 35: 1009-1015.
22. Boustany CM, Bharadwaj K, Daugherty A, Brown DR, Randall DC, Cassis LA. Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol 2004; 287: R943-R949.
23. Carroll JF, Zenebe WJ, Strange TB. Cardiovascular function in a rat model of diet-induced obesity. Hypertension 2006; 48: 65-72.
24. D'Angelo G, Mintz JD, Tidwell JE, Schreihofer AM, Pollock DM, Stepp DW. Exaggerated cardiovascular stress responses and impaired beta-adrenergic-mediated pressor recovery in obese Zucker rats. Hypertension 2006; 48: 1109-1115.
25. Sedova L, Berube J, Gaudet D, Dumont M, Tremblay J, Hamet P, Pausova Z. Diet-induced obesity delays cardiovascular recovery from stress in spontaneously hypertensive rats. Obes Res 2004; 12: 1951-1958.
26. Bianchi S, Bigazzi R, Baldari G, Sgherri G, Campese VM. Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens 1994; 7: 23-29.
27. Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, Porcellati C. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990; 81: 528-536.
28. Shimada K, Kawamoto A, Matsubayashi K, Nishinaga M, Kimura S, Ozawa T. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J Hypertens 1992; 10: 875-878.
29. Nakano S, Fukuda M, Hotta F, Ito T, Ishii T, Kitazawa M, Nishizawa M, Kigoshi T, Uchida K. Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects. Diabetes 1998; 47: 1501-1506.
30. Kohara K, Nishida W, Maguchi M, Hiwada K. Autonomic nervous function in non-dipper essential hypertensive subjects. Evaluation by power spectral analysis of heart rate variability. Hypertension 1995; 26: 808-814.
31. Schuler JL, O'Brien WH. Cardiovascular recovery from stress and hypertension risk factors: A meta-analytic review. Psychophysiology 1997; 34: 649-659.
32. Zanzinger J, Czachurski J. Chronic oxidative stress in the RVLM modulates sympathetic control of circulation in pigs. Pflugers Arch 2000; 439: 489-494.
33. Erdos B, Snipes JA, Tulbert CD, Katakam P, Miller AW, Busija DW. Rosuvastatin improves cerebrovascular function in Zucker obese rats by inhibiting NAD(P)H oxidase-dependent superoxide production. Am J Physiol Heart Circ Physiol 2006; 290: H1264-H1270.
34. Kvetnansky R, Micutkova L, Rychkova N, Kubovcakova L, Mravec B, Filipenko M, Sabban EL, Krizanova O. Quantitative evaluation of catecholamine enzymes gene expression in adrenal medulla and sympathetic Ganglia of stressed rats. Ann N Y Acad Sci 2004; 1018: 356-369.
35. Dogan MD, Sumners C, Broxson CS, Clark N, Tumer N. Central angiotensin II increases biosynthesis of tyrosine hydroxylase in the rat adrenal medulla. Biochem Biophys Res Commun 2004; 313: 623-626.
36. Tumer N, Larochelle JS. Tyrosine hydroxylase expression in rat adrenal medulla: Influence of age and cold. Pharmacol Biochem Behav 1995; 51: 775-780.
37. Takekoshi K, Ishii K, Isobe K, Nanmoku T, Kawakami Y, Nakai T. Angiotensin-II subtype 2 receptor agonist (CGP-42112) inhibits catecholamine biosynthesis in cultured porcine adrenal medullary chromaffin cells. Biochem Biophys Res Commun 2000; 272: 544-550.
38. Jezova M, Armando I, Bregonzio C, Yu ZX, Qian S, Ferrans VJ, Imboden H, Saavedra JM. Angiotensin II AT(1) and AT(2) receptors contribute to maintain basal adrenomedullary norepinephrine synthesis and tyrosine hydroxylase transcription. Endocrinology 2003; 144: 2092-2101.
39. Masuo K, Mikami H, Itoh M, Ogihara T, Tuck ML. Sympathetic activity and body mass index contribute to blood pressure levels. Hypertens Res 2000; 23: 303-310.